Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (151-160 of 290) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcomeTakashi Ishida, Atae Utsunomiya, Shinsuke Iida, et al.
Cancer Science|February 11, 2011
ABO blood group alleles and the risk of pancreatic cancer in a Japanese populationMakoto Nakao, Keitaro Matsuo, Satoyo Hosono, et al.
Frontiers in Oncology|March 6, 2023
Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with <i>KMT2A</i> rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like featuresTomotaka Suzuki, Rui Yokomori, Takaomi Sanda, et al.
Oncogene|August 5, 2020
Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphomaHaruhito Totani, Keiko Shinjo, Miho Suzuki, et al.
Cancer Medicine|July 20, 2024
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasoneTakuto Tachita, Masaki Ri, Sho Aoki, et al.
International Journal of Hematology|August 8, 2019
Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. TrialsMeletios A Dimopoulos, Philippe Moreau, Shinsuke Iida, et al.
Cancer Science|May 9, 2025
Immunosuppressive Effects of Multiple Myeloma-Derived Extracellular Vesicles Through T Cell ExhaustionShinya Hagiwara, Masaki Ri, Toru Ebina, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2008
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse modelAsahi Ito, Takashi Ishida, Hiroki Yano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Richter syndrome successfully treated with ibrutinib monotherapy: two case reports]Haruna Fujinami, Shigeru Kusumoto, Ayako Masaki, et al.
Nagoya Journal of Medical Science|December 17, 2021
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumorsTakuro Saito, Koji Kurose, Takashi Kojima, et al.
Pageof 29

Showing results (151-160 of 290) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcomeTakashi Ishida, Atae Utsunomiya, Shinsuke Iida, et al.
Cancer Science|February 11, 2011
ABO blood group alleles and the risk of pancreatic cancer in a Japanese populationMakoto Nakao, Keitaro Matsuo, Satoyo Hosono, et al.
Frontiers in Oncology|March 6, 2023
Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with <i>KMT2A</i> rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like featuresTomotaka Suzuki, Rui Yokomori, Takaomi Sanda, et al.
Oncogene|August 5, 2020
Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphomaHaruhito Totani, Keiko Shinjo, Miho Suzuki, et al.
Cancer Medicine|July 20, 2024
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasoneTakuto Tachita, Masaki Ri, Sho Aoki, et al.
International Journal of Hematology|August 8, 2019
Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. TrialsMeletios A Dimopoulos, Philippe Moreau, Shinsuke Iida, et al.
Cancer Science|May 9, 2025
Immunosuppressive Effects of Multiple Myeloma-Derived Extracellular Vesicles Through T Cell ExhaustionShinya Hagiwara, Masaki Ri, Toru Ebina, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2008
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse modelAsahi Ito, Takashi Ishida, Hiroki Yano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Richter syndrome successfully treated with ibrutinib monotherapy: two case reports]Haruna Fujinami, Shigeru Kusumoto, Ayako Masaki, et al.
Nagoya Journal of Medical Science|December 17, 2021
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumorsTakuro Saito, Koji Kurose, Takashi Kojima, et al.
Pageof 29